Cue Health (HLTH)
(Delayed Data from NSDQ)
$0.14 USD
0.00 (-3.09%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.14 0.00 (-0.71%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HLTH 0.14 0.00(-3.09%)
Will HLTH be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for HLTH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HLTH
Cue Health Inc. (HLTH) Reports Q4 Loss, Tops Revenue Estimates
Fulgent Genetics, Inc. (FLGT) Reports Q3 Loss, Tops Revenue Estimates
HLTH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Augmedix, Inc. (AUGX) Soars 7.6%: Is Further Upside Left in the Stock?
Cue Health Inc. (HLTH) Reports Q2 Loss, Tops Revenue Estimates
Cue Health Inc. (HLTH) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Other News for HLTH
Cue Health Announces CFO Transition and New Appointment
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
Cue Health Finalizes Separation Terms with Ex-Officer Khattak